Sagimet Biosciences Inc. - Series A Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 11/08/2026 | Sep 2025Filed 13/11/2025 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 11/08/2026 | Sep 2024Filed 13/11/2025 | Jun 2024Filed 13/11/2025 | Mar 2024Filed 13/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$14 | −$11 | −$13 | −$10 | −$18 | −$15 | −$8.1 | −$6.6 | |
| −$0.26 | −$0.33 | −$0.40 | −$0.32 | −$0.56 | −$0.45 | −$0.25 | −$0.23 | |
| 53 | 33 | 32 | 32 | 32 | 32 | 32 | 29 |
Trend